S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q2 2025

Deep Track Capital

Period: Q2 2025 Β· Filed: 2025-08-14
View on SEC EDGAR β†—
AUM
$3.12B
Total portfolio value
Positions
66
Reported securities
Top Holding
GH
7.1% $221.2M
QoQ Changes
+7 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
GHGUARDANT HEALTH INC$221.2M7.09%$52.04$167.98+222.8%
7.1%
IONSIONIS PHARMACEUTICALS INC$193.3M6.20%$39.51$81.80+107.0%
6.2%
PTGXPROTAGONIST THERAPEUTICS INC$179.4M5.75%$55.27$131.62+138.1%
5.8%
DVAXDYNAVAX TECHNOLOGIES CORP$176.5M5.66%β€”β€”
5.7%
INSMINSMED INC$176.1M5.65%$100.64$111.60+10.9%
5.7%
AKROAKERO THERAPEUTICS INC$162.3M5.21%β€”β€”
5.2%
IMVTIMMUNOVANT INC$152.0M4.87%$16.00$38.79+142.4%
4.9%
OCULOCULAR THERAPEUTIX INC$132.7M4.25%$9.28$9.64+3.9%
4.3%
APLSAPELLIS PHARMACEUTICALS INC$121.2M3.89%$17.31β€”
3.9%
CYTKCYTOKINETICS INC$120.6M3.87%$33.04$86.49+161.8%
3.9%
GPCRSTRUCTURE THERAPEUTICS INC$106.5M3.41%$20.74$53.45+157.7%
3.4%
ETNB89BIO INC$93.3M2.99%β€”β€”
3.0%
AXSMAXSOME THERAPEUTICS INC$83.7M2.68%$104.39$244.31+134.0%
2.7%
VRDNVIRIDIAN THERAPEUTICS INC$75.2M2.41%$13.98$19.40+38.8%
2.4%
TARSTARSUS PHARMACEUTICALS INC$70.9M2.27%$40.51$65.44+61.5%
2.3%
PCVXVAXCYTE INC$69.9M2.24%$32.51$58.39+79.6%
2.2%
NRIXNURIX THERAPEUTICS INC$69.1M2.22%$11.39$23.97+110.5%
2.2%
GERNGERON CORP$60.6M1.94%$1.41$1.36-3.5%
1.9%
IMCRIMMUNOCORE HLDGS PLC$56.5M1.81%$31.38$32.50+3.6%
1.8%
RAREULTRAGENYX PHARMACEUTICAL IN$49.1M1.57%$36.36$33.47-8.0%
1.6%
MAZEMAZE THERAPEUTICS INC$48.5M1.55%$12.27$31.26+154.8%
1.6%
ANIPANI PHARMACEUTICALS INC$45.7M1.46%$65.25$86.03+31.9%
1.5%
XENEXENON PHARMACEUTICALS INC$42.3M1.36%$31.30$60.96+94.8%
1.4%
DNTHDIANTHUS THERAPEUTICS INC$41.6M1.33%$18.63$94.34+406.4%
1.3%
CLDXCELLDEX THERAPEUTICS INC NEW$40.7M1.31%$20.35$38.37+88.5%
1.3%
BBIOBRIDGEBIO PHARMA INC$38.9M1.25%$43.18$77.19+78.8%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$38.4M1.23%$2.28$1.58-30.7%
1.2%
MTSRMETSERA INC$31.1M1.00%β€”β€”
1.0%
TERNTERNS PHARMACEUTICALS INC$28.0M0.90%$3.73β€”
0.9%
TECXTECTONIC THERAPEUTIC INC$27.9M0.89%$19.87$37.93+90.9%
0.9%

Quarter-on-Quarter Activity

Q2 2025 vs. Q1 2025

New Positions (7)

TickerIssuerNotionalSince Filing
AXSMAXSOME THERAPEUTICS INC$83.7M+134.0%
JBIOJADE BIOSCIENCES INC$25.1M
MRUSMERUS N V$14.5M
CDTXCIDARA THERAPEUTICS INC$12.2M
CBIOCRESCENT BIOPHARMA INC.$7.3M
CNTACENTESSA PHARMACEUTICALS PLC$6.6M
RAPTRAPT THERAPEUTICS INC$6.0M

Exited Positions (8)

TickerIssuerNotional
ITCIINTRA-CELLULAR THERAPIES INC$263.8M
AMGNAMGEN INC$35.2M
EWTXEDGEWISE THERAPEUTICS INC$30.8M
DYNDYNE THERAPEUTICS INC$20.9M
LKFTGALAPAGOS NV$18.6M
SAGESAGE THERAPEUTICS INC$16.2M
RAPTRAPT THERAPEUTICS INC$7.3M
BEAMBEAM THERAPEUTICS INC$6.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
INSMINSMED INC$156.7M+586.9%+10.9%
PCVXVAXCYTE INC$41.6M+186.7%+79.6%
BCYCBICYCLE THERAPEUTICS PLC$1.9M+56.9%
APLSAPELLIS PHARMACEUTICALS INC$11.8M+40.0%
XENEXENON PHARMACEUTICALS INC$8.7M+35.0%+94.8%
TERNTERNS PHARMACEUTICALS INC$12.6M+34.4%
ORKAORUKA THERAPEUTICS INC$6.7M+32.8%
IMCRIMMUNOCORE HLDGS PLC$14.6M+27.5%+3.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
SEPNSEPTERNA INC$-9.8M-93.6%
RAPPRAPPORT THERAPEUTICS INC$-3.5M-78.5%
SRPTSAREPTA THERAPEUTICS INC$-53.0M-71.1%
KRROKORRO BIO INC$-11.8M-68.2%
BBIOBRIDGEBIO PHARMA INC$-57.9M-67.9%+78.8%
OKURONKURE THERAPEUTICS INC$-1.8M-65.6%
SRPTSAREPTA THERAPEUTICS INC$-49.7M-50.0%
ZURAZURA BIO LTD$-2.4M-47.4%
← Back to Hedge Funds